Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 191

1.

Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.

Haines ML, Ajlouni Y, Irving PM, Sparrow MP, Rose R, Gearry RB, Gibson PR.

Inflamm Bowel Dis. 2011 Jun;17(6):1301-7. doi: 10.1002/ibd.21458. Epub 2010 Sep 1.

PMID:
20812329
[PubMed - indexed for MEDLINE]
2.

Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis.

Wusk B, Kullak-Ublick GA, Rammert C, von Eckardstein A, Fried M, Rentsch KM.

Eur J Gastroenterol Hepatol. 2004 Nov;16(12):1407-13.

PMID:
15618853
[PubMed - indexed for MEDLINE]
3.

Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.

Andoh A, Tsujikawa T, Ban H, Hashimoto T, Bamba S, Ogawa A, Sasaki M, Saito Y, Fujiyama Y.

J Gastroenterol Hepatol. 2008 Sep;23(9):1373-7. doi: 10.1111/j.1440-1746.2008.05419.x. Epub 2008 Jul 23.

PMID:
18662197
[PubMed - indexed for MEDLINE]
4.

Monitoring 6-thioguanine nucleotide concentrations in Japanese children and adolescents with inflammatory bowel disease.

Ohtsuka Y, Arai K, Aoyagi Y, Fujii T, Yamakawa Y, Ohtani K, Ikuse T, Baba Y, Inage E, Kudo T, Suzuki R, Nagata S, Shimizu T.

J Gastroenterol Hepatol. 2010 Oct;25(10):1626-30. doi: 10.1111/j.1440-1746.2010.06364.x.

PMID:
20880170
[PubMed - indexed for MEDLINE]
5.

The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease.

Goldenberg BA, Rawsthorne P, Bernstein CN.

Am J Gastroenterol. 2004 Sep;99(9):1744-8.

PMID:
15330913
[PubMed - indexed for MEDLINE]
6.

Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease.

Wright S, Sanders DS, Lobo AJ, Lennard L.

Gut. 2004 Aug;53(8):1123-8.

PMID:
15247179
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Next steps on the thiopurine methyltransferase 6-thioguanine nucleotide pathway.

Colletti RB.

J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):282-3. No abstract available.

PMID:
16954947
[PubMed - indexed for MEDLINE]
8.

Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.

Gilissen LP, Wong DR, Engels LG, Bierau J, Bakker JA, Paulussen AD, Romberg-Camps MJ, Stronkhorst A, Bus P, Bos LP, Hooymans PM, Stockbrügger RW, Neef C, Masclee AA.

J Crohns Colitis. 2012 Jul;6(6):698-707. doi: 10.1016/j.crohns.2011.12.003. Epub 2012 Jan 10.

PMID:
22398098
[PubMed - indexed for MEDLINE]
9.
10.

Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.

Armstrong L, Sharif JA, Galloway P, McGrogan P, Bishop J, Russell RK.

Aliment Pharmacol Ther. 2011 Nov;34(9):1106-14. doi: 10.1111/j.1365-2036.2011.04848.x. Epub 2011 Sep 19.

PMID:
21929546
[PubMed - indexed for MEDLINE]
11.

Thiopurine metabolite monitoring in paediatric inflammatory bowel disease.

Ooi CY, Bohane TD, Lee D, Naidoo D, Day AS.

Aliment Pharmacol Ther. 2007 Apr 15;25(8):941-7.

PMID:
17402998
[PubMed - indexed for MEDLINE]
Free Article
12.

5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.

Hande S, Wilson-Rich N, Bousvaros A, Zholudev A, Maurer R, Banks P, Makrauer F, Reddy S, Burakoff R, Friedman S.

Inflamm Bowel Dis. 2006 Apr;12(4):251-7.

PMID:
16633046
[PubMed - indexed for MEDLINE]
13.

Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD.

Govani SM, Higgins PD.

J Crohns Colitis. 2010 Oct;4(4):444-9. doi: 10.1016/j.crohns.2010.02.009. Epub 2010 Mar 21.

PMID:
21122542
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.

Hoentjen F, Seinen ML, Hanauer SB, de Boer NK, Rubin DT, Bouma G, Harrell LE, van Bodegraven AA.

Inflamm Bowel Dis. 2013 Feb;19(2):363-9. doi: 10.1002/ibd.23021.

PMID:
22605661
[PubMed - indexed for MEDLINE]
15.

A validated HPLC method for the monitoring of thiopurine metabolites in whole blood in paediatric patients with inflammatory bowel disease.

Cangemi G, Barabino A, Barco S, Parodi A, Arrigo S, Melioli G.

Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):435-44.

PMID:
22697075
[PubMed - indexed for MEDLINE]
16.

Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.

Dilger K, Schaeffeler E, Lukas M, Strauch U, Herfarth H, Müller R, Schwab M.

Ther Drug Monit. 2007 Feb;29(1):1-5.

PMID:
17304143
[PubMed - indexed for MEDLINE]
17.

The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.

Ban H, Andoh A, Imaeda H, Kobori A, Bamba S, Tsujikawa T, Sasaki M, Saito Y, Fujiyama Y.

J Gastroenterol. 2010 Oct;45(10):1014-21. doi: 10.1007/s00535-010-0248-y.

PMID:
20393862
[PubMed - indexed for MEDLINE]
18.

Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.

Gearry RB, Barclay ML.

J Gastroenterol Hepatol. 2005 Aug;20(8):1149-57. Review.

PMID:
16048561
[PubMed - indexed for MEDLINE]
19.

Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center.

Banerjee S, Bishop WP.

J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):324-30.

PMID:
16954954
[PubMed - indexed for MEDLINE]
20.

Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients.

González-Lama Y, Bermejo F, López-Sanromán A, García-Sánchez V, Esteve M, Cabriada JL, McNicholl AG, Pajares R, Casellas F, Merino O, Carpio D, Vera MI, Muñoz C, Calvo M, Benito LM, Bujanda L, García-Fernández FJ, Ricart E, Ginard D, Velasco M, Carneros JA, Manceñido N, Calvo M, Algaba A, Froilan C, Cara C, Maté J, Abreu L, Gisbert JP; "Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)".

Aliment Pharmacol Ther. 2011 Sep;34(5):544-54. doi: 10.1111/j.1365-2036.2011.04756.x. Epub 2011 Jul 3.

PMID:
21722149
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk